BioIntellisense
Developer of a clinical intelligence platform designed for continuous health monitoring, predictive analytics, and algor
Monitoring Equipment
📍 Golden, CO
Founded 2019
Current Valuation
$1.2B
as of 2022-Q4
UNICORN
Developer of a clinical intelligence platform designed for continuous health monitoring, predictive analytics, and algorithmic clinical insights.
Company Profile
Last Round
Early Stage VC — $178.6M (Dec 2022)
Fundraising Status
Early Stage VC · $178.6M · 3y 8mo ago
privateTotal raised $260.6M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Early Stage VC | $178.6M | Dec 2022 | — | $1.2B |
Health CareBiotechnologyMedical Device
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q4. Refreshed quarterly.